FOLH1 and prostate carcinoma: Prostate-specific membrane antigen (PSMA) is a transmembrane protein that has been shown to be significantly overexpressed in human prostate carcinoma and to a lesser extent in tumor neovasculature of various solid tumor histologies [13, 14].